Microbiology & Infectious Diseases

An international study has uncovered significant effects of two widely used neurological drugs, entacapone and loxapine succinate, on gut microbial communities.

Approximately 1 in 20 individuals diagnosed with RSV in outpatient settings were hospitalised within 28 days.

A recent study has revealed that the gut microbiota plays a critical role in tamoxifen’s metabolism, influencing its absorption and bioavailability.

Nirmatrelvir/ritonavir reduced hospitalisations, symptom duration, and healthcare resource utilisation in high-risk, unvaccinated adults with mild-to-moderate COVID-19.

A new study has identified inflammatory biomarkers linked to long COVID in patients with systemic autoimmune rheumatic diseases.

Emerging research highlights the oral microbiome’s potential role in maternal mental health, suggesting an oral-brain-behaviour axis distinct from the gut-brain axis.

Research highlights the emergence of artemisinin partial resistance in Ugandan children with complicated malaria, a development with significant implications for treatment protocols in high-burden regions.

Novel research has challenged conventional thinking around microbial associations with diseases like inflammatory bowel disease and colorectal cancer.